Pfizer Inc - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, Pfizer Inc held in its portfolio 18 assets valued at $236,464,562 (i.e. $236.47M).
The most valuable assets in the portfolio included: ORIC PHARMACEUTICALS INC ($43.98M), ARVINAS INC ($41.01M), and CELCUITY INC ($34.85M).
The chart below shows the top 10 valuable assets, and the table below shows the top 18 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Pfizer Inc - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| ORIC PHARMACEUTICALS INC | 5376344 | 43978494 | COM |
| ARVINAS INC | 3457815 | 41009686 | COM |
| CELCUITY INC | 349406 | 34849754 | COM |
| WAVE LIFE SCIENCES LTD | 1875000 | 31875000 | SHS |
| ALLOGENE THERAPEUTICS INC | 22032040 | 30183895 | COM |
| ZURA BIO LTD | 2970022 | 15562915 | CLASS A ORD SHS |
| PYXIS ONCOLOGY INC | 7032770 | 8087685 | COMMON STOCK |
| CARIBOU BIOSCIENCES INC | 4690431 | 7457785 | COM |
| CARDIFF ONCOLOGY INC | 2411575 | 6776526 | COM |
| BIOHAVEN LTD | 505645 | 5708732 | COM |
| SPERO THERAPEUTICS INC | 2362348 | 5504271 | COM |
| NEXTCURE INC | 157646 | 2236997 | COM NEW |
| ZENTALIS PHARMACEUTICALS INC | 953834 | 1287675 | COM |
| Q32 BIO INC | 277777 | 922220 | COM |
| AN2 THERAPEUTICS INC | 715295 | 815436 | COM |
| BOLT BIOTHERAPEUTICS INC | 31305 | 171176 | COM NEW |
| GINKGO BIOWORKS HOLDINGS INC | 2928 | 24332 | CL A NEW |
| SENSEONICS HLDGS INC | 2171 | 11983 | COM |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.